Revenue: The sum of all revenue fields included for a company's operating activities.
Anebulo Pharmaceuticals, Inc. (ANEB) Revenue data is not available.
| Income Statement Financials | |
|
Revenue |
-- |
$-2.14M |
|
-- |
|
-- |
|
$2.33M |
|
$-2.33M |
|
$0.19M |
|
$-2.14M |
|
$-2.14M |
|
$-2.14M |
|
$-2.14M |
|
$-2.14M |
|
$-2.14M |
|
$-2.33M |
|
$-2.31M |
|
33.82M |
|
33.82M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$11.96M |
|
-- |
|
$0.18M |
|
$12.15M |
|
$0.49M |
|
-- |
|
-- |
|
$0.49M |
|
$11.66M |
|
$11.66M |
|
$11.66M |
|
41.09M |
|
| Cash Flow Statement Financials | |
$-6.35M |
|
-- |
|
$14.88M |
|
$3.09M |
|
$11.63M |
|
$8.53M |
|
$1.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.40% |
|
-18.40% |
|
-17.66% |
|
-18.40% |
|
$0.28 |
|
$-0.19 |
|
$-0.19 |
|